A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. [electronic resource]
Producer: 20180214Description: 832-8 p. digitalISSN:- 1815-7920
- Adolescent
- Adult
- Aged
- Antitubercular Agents -- therapeutic use
- Dose-Response Relationship, Drug
- Ethambutol -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Isoniazid -- therapeutic use
- Male
- Middle Aged
- Patient Compliance
- Pyrazinamide -- therapeutic use
- Rifampin -- therapeutic use
- Treatment Outcome
- Tuberculosis, Pulmonary -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.